V. REFERENCES 



142. Varsano, I.; Fischl, J.; Shochet, SB (1973) 

 The excretion of orally ingested nitrofurantoin 

 in human milk. J. Pediatr. 82:886-887. 



143. Veronese, M.; Salvaterra, M.; Barzaghi, D.; 

 Setnikar, I. (1974) Urinary excretion in the rat 

 of nifurpipone (NP) and of nitrofurantoin (NTF) 

 administered by different routes. Arzneimittel- 

 forschung 24:39-43. 



144. Wang, C.Y.; Lee, L.H. (1976) Mutagenic ac- 

 tivity of carcinogenic and noncarcinogenic nitro- 

 furans and of urine of rats fed these compounds. 

 Chem. Biol Interact. 15:69-75. 



145. Whitcomb, M.E.; Domby, W.R. (1978) Drug- 

 induced lung disease. Primary Care 5:41 1-421 



146. Wierzba, K.; Wankowicz, B.; Rogoyski, A.; 

 Prokopczyk, J ; Piekarczyk, A.; Kaminska, E ; 

 Bozkowa, K (1982) Experimental and clinical 

 pharmacokinetics of nitrofurantoin in the early 

 period of life, Padiatr. Padol. 17:293-299. 



147. Yahagi, T.; Nagao, M.; Hara, K.; Matsushi- 

 ma, T.; Sugimura, T.; Bryan, G.T (1974) Rela- 

 tionships between the carcinogenic and muta- 

 genic or DNA-modifying effects of nitrofuran 

 derivatives, including 2-(2-furyl)-3-(5-nitro-2- 

 furyDacrylamide, a food additive. Cancer Res. 

 34:2266-2273. 



148. Yiannikas, C . Pollard, J.D.; McLeod, J.G. 

 (1981) Nitrofurantoin neuropathy. Aust. N.Z. J. 

 Med. 11:400-405. 



149. Zeiger, E.; Pagano, DA; Robertson, I.G.C. 

 (1981) Rapid and simple scheme for confirma- 

 tion of Salmonella tester strain phenotype. En- 

 viron. Mutagen. 3:205 209 



150 Zimmering, S ; Mason, J.M.; Valencia, R.; 

 Woodruff, R.C (1985) Chemical mutagenesis 

 testing in Drosophila 11 Results of 20 coded 

 compounds tested for the National Toxicology 

 Program. Environ. Mutagen. 7:87-100. 



75 



Nitrofurantoin, NTP TR 341 



